Evidence map›Paper›PMID 38420555›Full record

ArticleJTCVS open2024

Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer.

Rishindra M Reddy, Kiran Lagisetty, Jules Lin, Andrew C Chang, Abhinav Achreja, Nithya Ramnath, Deepak Nagrath, Robert Dickson, Frank Weinberg

Open access · goldAbstract read
In one paragraph

Article in JTCVS open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rishindra M ReddySection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.
Kiran LagisettySection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.
Jules LinSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.
Andrew C ChangSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.
Abhinav AchrejaBiomedical Engineering, University of Michigan, Ann Arbor, Mich.
Nithya RamnathHematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
Deepak NagrathBiomedical Engineering, University of Michigan, Ann Arbor, Mich.
Robert DicksonPulmonary/Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
Frank WeinbergHematology/Oncology, Department of Internal Medicine, University of Illinois-Chicago, Chicago, Ill.
University of Michigan · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Data are scarce on whether the composition of the lung microbiome (extending from the nasopharynx to the peripheral lung tissue) varies according to histology or grade of non-small cell lung cancer. We hypothesized that the composition of the lung microbiome would vary according to the histology and the grade of non-small cell lung cancer. Methods: We collected naso-oral and central lobar (cancer affected, ipsilateral unaffected, and contralateral unaffected) bronchoalveolar lavage fluid and brushing samples from patients with clinical early-stage lung cancer between July 2018 and February 2020 at a single academic center. We performed bacterial 16S rRNA sequencing and then compared clinical and pathologic findings with microbiome signatures. Results: Samples were collected from 28 patients. Microbial composition in affected lobes displayed unique enrichment of oropharyngeal bacterial species that was significantly different compared with that from the unaffected contralateral lobes; patients with chronic obstructive pulmonary disease had similar diversity to those without chronic obstructive pulmonary disease ( Conclusions: The lung microbiota differs between cancer affected and unaffected lobes in the same patient. Furthermore, poorly differentiated lung cancers were associated with lower microbial diversity. Larger studies will be required to confirm these findings.

Indexed as

lung cancerlung microbiomemicrobiome diversitypoorly differentiated

Identifiers

PMID38420555
PMCPMC10897652
OpenAlexW4389194778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.